Experience With the Use of Rituximab for the Treatment of Rheumatoid Arthritis in a Tertiary Hospital in Spain: RITAR Study

There is evidence supporting that there are no relevant clinical differences between dosing rituximab 1000 mg or 2000 mg per cycle in rheumatoid arthritis (RA) patients in clinical trials, and low-dose cycles seem to have a better safety profile. Our objective was to describe the pattern of use of r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Rheumatol
Main Authors: Cañamares, Iciar, Merino, Leticia, López, Jorge, Llorente, Irene, García-Vadillo, Alberto, Ramirez, Esther, López-Bote, Juan Pedro, Benedí, Juana, Muñoz-Calleja, Cecilia, Álvaro-Gracia, José M., Castañeda, Santos, González-Álvaro, Isidoro
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6727960/
https://ncbi.nlm.nih.gov/pubmed/30001257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RHU.0000000000000845
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados